Alnylam Pharmaceuticals | هزینه بهره بدهی



Interest Expense On Debt تغییر دادن تاریخ
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 40.25M 1.6M 2025-06
Amgen USD 694M 29M 2025-06
Arrowhead Research USD 24.38M 2.74M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Incyte USD 594K 66K 2025-06
Ionis Pharmaceuticals USD 19M 0 2025-06
Moderna USD 1000K 0 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
PTC Therapeutics USD 30.36M 4.03M 2025-06
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Sanofi 66.11M 20.67M 2024-12
Sarepta Therapeutics USD 5.23M 725K 2025-06
Takeda 107.16B 56.83B 2025-06
Tectonic Therapeutic USD 22K 3K 2024-12
Ultragenyx Pharmaceutical 14.04M 1.48M 2025-06
Vertex Pharmaceuticals USD 3.7M 900K 2025-06
Xencor 8.24M 422K 2025-06


Alnylam Pharmaceuticals هزینه بهره بدهی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Aug 2025.